Gwyneth Bejer
KPJ Healthcare unveils first ‘Centre of Excellence' at Johor hospital
KPJ Healthcare unveils first ‘Centre of Excellence' at Johor hospital
It is the first of 15 planned CoEs to be established by 2030.
New $72.7m Cowra Hospital set to open in NSW, Australia
All existing campus services will begin on 9 December.
NSW ‘Hospital in the Home’ programme to expand with $20.8m funding
The expansion includes wearable monitoring technology to track vital signs in real time.
IVD labware market to be valued at $5.04b by 2030
By end user, the clinical laboratories segment held the largest market share in 2024.
Australia invests $6.3m in research on high-use health service patients
Four projects will examine healthcare delivery and develop improved models.
Sterling Hospitals launches ER ambulance service in Ahmedabad
It features a command centre and real-time in-house monitoring.
Airway management devices market to hit $3.82b
By end user, the hospitals segment dominated 68% of the market share in 2024.
Avisena Healthcare to open specialist clinic in Cyberjaya, Malaysia
This facility will lead to the launch of a new specialist hospital in 2028.
Australian gov’t invests $11.8m in NSW paediatric allied health expansion
The funding covers the appointment of 32 health professionals.
TMC Clinic expands lab services across Visayas, Mindanao locations
The group now offers over 100 special laboratory tests.
7MM CKD-HPT, HP, and HK market to reach $4b by 2034
However, high expected therapy costs may limit patient access.
Wyong Hospital completes stage 3 of $131.5m redevelopment
The expanded Wyong Cancer Centre is now operational.
KPJ Healthcare to expand diagnostic services nationwide in new partnership
The group will link its radiology services with Qualitas Health’s primary care network.
Kapadia Hospital adopts MISSO system for knee replacement surgeries
The platform uses real-time data to create a 3D model of a patient’s anatomy.
Sydney Children’s Hospital Randwick opens in Australia
The facility supports a ‘whole of campus’ approach.
In-silico clinical trials market to hit $6.39b by 2033
Drug development represented the largest market share.
Australia invests $4.3m in anal cancer research
Four projects will develop screening, prevention, technology, and health initiatives.
Commentary
Public health at scale: Lessons from implementing AI across government health programmes
Clearing the air: Why Singapore's haze problem is an eldercare crisis in plain sight
Beyond ChatGPT: The rise of multimodal AI assistants in clinical settings